GIS
47
13
EA
41
3
DG
14
6
MU
42
14
PSA
43
6
TMO
52
8
ROP
44
6
HAS
29
3
MO
47
6
AIG
38
5
CCI
30
2
XYL
29
4
IR
46
3
ILMN
31
4
OXY
42
17
NTAP
58
3
EOG
28
2
BK
60
2
HCP
54
2
O
26
16
GIS
47
13
EA
41
3
DG
14
6
MU
42
14
PSA
43
6
TMO
52
8
ROP
44
6
HAS
29
3
MO
47
6
AIG
38
5
CCI
30
2
XYL
29
4
IR
46
3
ILMN
31
4
OXY
42
17
NTAP
58
3
EOG
28
2
BK
60
2
HCP
54
2
O
26
16
Financhill
Back

Chicago Atlantic Real Estate Finance Vs. Novo Nordisk AS Industry Stock Comparison

Sell
35

REFI
Chicago Atlantic Real Estate Finance

Last Price:
$15.98
Seasonality Move:
-3.38%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Sell
35
Chicago Atlantic Real Estate Finance (REFI) is a Sell

Is Chicago Atlantic Real Estate Finance a Buy, Sell or Hold?

  • The current Chicago Atlantic Real Estate Finance [REFI] share price is $15.98. The Score for REFI is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • REFI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

REFI Stock Price Chart

What is Chicago Atlantic Real Estate Finance's stock price today?

  • The Chicago Atlantic Real Estate Finance share price today is $15.98
    The current trend is relatively stagnant and REFI is experiencing buying pressure, which is a positive indicator for future bullish movement.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

REFI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 50.8 Buy
Chaikin Money Flow: 165294 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.88 - 16.18) Sell
Bollinger Bands (100): (15.36 - 16.02) Buy

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

REFI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.03 Sell
20-day SMA: 16.08 Sell
50-day SMA: 15.75 Buy
200-day SMA: 15.71 Buy
8-day EMA: 15.99 Sell
20-day EMA: 15.99 Sell
50-day EMA: 15.85 Buy
200-day EMA: 15.69 Buy

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

Chicago Atlantic Real Estate Finance Earnings Growth & REFI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.08 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Chicago Atlantic Real Estate Finance Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):